Skip to content
New: 100+ more US companies, including the big banks, plus insider trades from SEC filings

Consumer Staples · NYSE: CLX

Clorox: how the business works

Clorox makes bleach, Glad bags, Brita filters and, since April 2026, Purell hand sanitizer, with $6.72 billion of net sales in FY2026.

By · Checked against filings: . Editorial policy. Corrections

Follow Clorox

Email me when Clorox's page is updated after earnings.

We'll send a confirmation email first. See our privacy policy.

The Clorox Company · Oakland, California · Founded 1913

Updated for Q1 FY2027 · checked

Net sales, FY2026
$6.72B
Net income attributable to Clorox, FY2026
$587M
Walmart's share of net sales, FY2026
26%
Employees, Jun 30, 2026
About 9,200
Founded
1913

For learning only. Cityfort is not a registered investment adviser or broker-dealer and does not recommend buying or selling any security. Prices shown are dated and may be out of date.

The short version

Clorox in 5 points

  1. 1 · What it sells

    Clorox sells household brands such as Clorox bleach and wipes, Glad bags, Kingsford charcoal, Brita and, since Apr 1, 2026, Purell, with $6,720 million of net sales in FY2026.

    More: what it sells

  2. 2 · Who pays it

    Walmart accounted for 26% of Clorox's FY2026 net sales, its next four largest customers for about 24% and all other customers for about 50%.

    More: who pays it

  3. 3 · What it keeps from $100

    Of every $100 that came in during FY2026, Clorox kept $8.72 as net income, which includes $8 million of non-operating other income, net; Clorox reports no operating income line, and EBIT, a non-GAAPThe company's own "adjusted" numbers, not the official (GAAP) ones. Always read them next to the official figure. Learn more measure Clorox reports, was $913 million.

    More: what it keeps from $100

  4. 4 · Where the operating profit comes from

    Health and Wellness, the cleaning and Purell segment, earned $678 million, about 57%, of the $1,191 million of FY2026 segment adjusted EBIT from Clorox's four segments.

    More: where the operating profit comes from

  5. 5 · The one thing to watch

    On Nov 2, 2026 Clorox said it now expects FY2027 gross margin of about 41.5%, against about 42% in its Aug 3, 2026 outlook, after a Q1 FY2027 gross margin of 40.4%.

    More: the one thing to watch

Sources: From Clorox's FY2026 10-K and its Q4 FY2026 and Q1 FY2027 earnings releases · checked

01Where the money goes · FY2026

Where does $100 of Clorox's money go?

Of every $100 that came in (revenue plus other income), this is where it went.

Clorox · FY2026

Receipt for every $100

Where $100 of Clorox's money went in FY2026
Cost of products sold$57.6
Selling, administration and research$17.6
Advertising$11.1
Interest and income taxes$4.8
Share of outside partners$0.2
Kept as net income$8.7
Total$100

Each line = amount ÷ total money in × 100. Lines may not add to exactly $100 because of rounding.

How this is worked out

Cityfort calculation from the FY2026 10-K. Of every $100 that came in during FY2026 (net sales of $6,720 million plus $8 million of other income, net): each line = line ÷ $6,728 million × 100.

Save this receipt as an image

Embed this receipt or the key numbers

Paste this code into a blog or website to show the card you choose, with a link back to this page.

Each week: the next company due to report earnings, explained in 5 points.

No tips. Unsubscribe anytime.

We'll send a confirmation email. See our privacy policy.

02The business in one line

What does Clorox do?

Shoppers buy Clorox brands at Walmart and other stores; most of the money goes on making the products and advertising them, and Clorox kept $8.72 of every $100 as net income in FY2026.

  • Walmart alone paid for 26% of Clorox's FY2026 net sales, and the five largest customers for about half.
  • Making the products took $57.61 of every $100 in FY2026, and advertising took $11.13.

03Who pays it

Who pays Clorox?

  • Walmart

    26%

    of revenue

    Walmart Stores and its affiliates buy across all four segments. They were Clorox's largest customer, at 26% of FY2026 net sales, 27% in FY2025 and 25% in FY2024.

  • Other retailers in the US

    Share of revenue not disclosed

    Grocery chains, warehouse clubs, dollar stores, hardware, drug and pet stores, the military and online sellers. No other single customer reached 10% of net sales in FY2026.

  • Professional buyers

    8%

    of revenue

    Hospitals, schools, offices and restaurants, mostly reached through distributors. Professional products were 8% of FY2026 net sales, up from 5%, after GOJO joined.

  • Buyers outside the US

    17%

    of revenue

    Retailers and distributors in the International segment, which was 17% of FY2026 net sales.

  • Walmart26%
  • Professional buyers8%
  • Buyers outside the US17%

Customer concentration

Walmart alone was 26% of FY2026 net sales; the 10-K says the five largest customers were about half of net sales in each of FY2024, FY2025 and FY2026.

Largest customer
26%
Top 5 customers
50%

04How it makes money

How does Clorox make money?

Clorox earns from brands that shoppers buy again and again, at prices above store brands.

Clorox says over 80% of its sales come from brands that are No. 1 or No. 2 in their categories, and that its products compete on performance and brand reputation, among other things. It spent $749 million on advertising in FY2026. Gross profit per $100 of sales was $35.8 in FY2022, when product costs rose, and $45.2 in FY2025.

Gross profit per $100 of net sales

$35.8$42.3

FY2022 to FY2026

  1. Advertise brands such as Clorox, Glad and Brita
  2. Shoppers buy the brand instead of a store brand
  3. Retailers such as Walmart stock the brands
  4. Steady repeat sales cover factory and ad costs
  5. Gross profit pays for more advertising and dividends

↺ Step 5 feeds back into step 1.

05Business segments · FY2026

Which businesses make up Clorox?

  • Health and Wellness

    40.1%

    Cleaning, Purell and professional products. Segment adjusted EBIT, Clorox's segment profit measure, was $678 million, $25.1 per $100 of sales (Cityfort calculation from the FY2026 10-K).

    Revenue $2.7B ($2,697M) · Operating profit $678M

  • Household

    26.6%

    Glad, cat litter and Kingsford charcoal. Net sales fell 11% in FY2026 and segment adjusted EBIT fell from $325 million to $192 million.

    Revenue $1.8B ($1,787M) · Operating profit $192M

  • Lifestyle

    16.7%

    Hidden Valley, Brita and Burt's Bees. Net sales fell 14% in FY2026, the largest drop of the four.

    Revenue $1.1B ($1,123M) · Operating profit $208M

  • International

    16.6%

    Sales outside the US. The only segment with organic growth (growth leaving out acquisitions, business sales and currency) in FY2026, at 2%.

    Revenue $1.1B ($1,113M) · Operating profit $113M

How the mix changed

  • Health and Wellness
  • Household
  • Lifestyle
  • International

Revenue by segment, FY2023 to FY2026.

US$

See the numbers
How the mix changed (US$)
YearHealth and WellnessHouseholdLifestyleInternational
FY2023$2.5B$2.1B$1.3B$1.2B
FY2024$2.5B$2.0B$1.3B$1.2B
FY2025$2.7B$2.0B$1.3B$1.1B
FY2026$2.7B$1.8B$1.1B$1.1B

06The numbers · Consolidated · US$

How has Clorox done?

Revenue

$6.7BFY2026

Net sales fell 5% to $6,720 million in FY2026, as retailers ran down stock they had built before Clorox switched its US ordering systems in 2025.

US$

See the numbers
Revenue (US$)
PeriodRevenue (US$)
FY2022$7.1B
FY2023$7.4B
FY2024$7.1B
FY2025$7.1B
FY2026$6.7B
Q2 FY2024$2.0B
Q3 FY2024$1.8B
Q4 FY2024$1.9B
Q1 FY2025$1.8B
Q2 FY2025$1.7B
Q3 FY2025$1.7B
Q4 FY2025$2.0B
Q1 FY2026$1.4B
Q2 FY2026$1.7B
Q3 FY2026$1.7B
Q4 FY2026$1.9B
Q1 FY2027$1.9B

Net income

$587MFY2026

Net income attributable to Clorox ranged from $149 million in FY2023, a year with $445 million of impairments, to $810 million in FY2025, then fell to $587 million in FY2026.

US$

See the numbers
Net income (US$)
PeriodNet income (US$)EPS ($)
FY2022$462M$3.73
FY2023$149M$1.20
FY2024$280M$2.25
FY2025$810M$6.52
FY2026$587M$4.81
Q2 FY2024$93M$0.75
Q3 FY2024−$51M−$0.41
Q4 FY2024$216M$1.73
Q1 FY2025$99M$0.80
Q2 FY2025$193M$1.54
Q3 FY2025$186M$1.50
Q4 FY2025$332M$2.68
Q1 FY2026$80M$0.65
Q2 FY2026$157M$1.29
Q3 FY2026$187M$1.54
Q4 FY2026$163M$1.34
Q1 FY2027$170M$1.39

Net income for every $100 of revenue

$8.7FY2026

Clorox reports no operating income line, so EBITDA is a Cityfort calculation from the FY2022 to FY2026 10-Ks and the earnings releases (earnings before taxes, plus interest expense less interest income, plus depreciation and amortization). It was $17.3 per $100 of net sales in FY2026, down from $19.4 in FY2025.

Net margin: $ of net income per $100 of revenue

See the numbers
Net income for every $100 of revenue (Net margin: $ of net income per $100 of revenue)
YearNet marginEBITDA margin
FY20226.5%13.1%
FY20232.0%7.4%
FY20243.9%9.9%
FY202511.4%19.4%
FY20268.7%17.3%

Free cash flow

$405MFY2026

Free cash flow fell to $405 million in FY2026 from $761 million, partly because the $476 million paid to P&G for its 20% share of Glad counted as operating cash outflow.

US$ · cash from operations minus spending on plants and equipment

See the numbers
Free cash flow (US$ · cash from operations minus spending on plants and equipment)
YearCash from operationsCapital spendingFree cash flow
FY2022$786M$251M$535M
FY2023$1.2B$228M$930M
FY2024$695M$212M$483M
FY2025$981M$220M$761M
FY2026$612M$207M$405M
See all yearly numbers
Clorox annual financials, FY2022–FY2026, US$
YearRevenueEBITDANet incomeEPS ($)Operating cashCapexFree cash
FY2022$7.1B$932M$462M$3.73$786M$251M$535M
FY2023$7.4B$548M$149M$1.20$1.2B$228M$930M
FY2024$7.1B$700M$280M$2.25$695M$212M$483M
FY2025$7.1B$1.4B$810M$6.52$981M$220M$761M
FY2026$6.7B$1.2B$587M$4.81$612M$207M$405M

EBITDA here = operating income plus depreciation and amortization (from the cash flow statement). Fiscal years are the company's own: Fiscal year ends June 30; FY2026 is the year ended Jun 30, 2026, and Q1 FY2027 the quarter ended Sep 30, 2026. Net income is the share belonging to the company's owners.

Learn: Fiscal years that don't end in December: Nvidia's FY2027 explained · Stock-based compensation and dilution: pay that becomes shares

07Who runs it

Who runs Clorox, and did they deliver?

  • Linda Rendle

    Chair and Chief Executive Officer · since 2020

    CEO since Sep 2020 and Chair since Jan 2024; the 2026 proxy says she has served 23 years at Clorox, six of them as CEO. On May 28, 2026 Clorox announced she had asked the Board to start a CEO search for health reasons. On Oct 28, 2026 the Board named Fabian Garcia as her successor; she steps down as CEO and Chair on Jan 5, 2027 and stays as a senior advisor through Apr 2, 2027.

  • Fabian Garcia

    Chief Executive Officer (from Jan 5, 2027) · since 2027

    Appointed by the Board on Oct 28, 2026 as CEO and director, effective Jan 5, 2027. He has been Business Group President, Personal Care at Unilever since 2022, and was CEO of Revlon from 2016 to 2018.

  • Luc Bellet

    Executive Vice President and Chief Financial Officer · since 2025

    CFO since Apr 2025; previously Clorox treasurer.

  • Chris Hyder

    Executive Vice President and Chief Operating Officer · since 2026

    COO since Jun 2026.

  • Nina Barton

    Executive Vice President and Chief Growth and Strategy Officer · since 2026

    In the role since Jun 2026.

  • Carey Jaros

    President, Clorox Purell · since 2026

    Leads the former GOJO business, based in Akron, Ohio, since the Apr 1, 2026 acquisition.

What they said, and what happened

1 delivered · 1 missed · 2 too early to tell

  1. Said on Apr 30, 2026

    On Apr 30, 2026, with GOJO included, management said FY2026 net sales would fall about 6%, with diluted EPS of $4.78 to $4.98 and adjusted EPS of $5.45 to $5.65.

    What happened

    FY2026 net sales fell 5%, diluted EPS was $4.81 and adjusted EPS $5.53.

    Delivered
  2. Said on Feb 3, 2026

    On Feb 3, 2026, before the GOJO deal closed, management said FY2026 diluted EPS would be $5.60 to $5.95 and adjusted EPS $5.95 to $6.30.

    What happened

    Diluted EPS was $4.81 and adjusted EPS $5.53. The Apr 30, 2026 outlook had already lowered the ranges and added GOJO.

    Missed
  3. Said on Jan 22, 2026

    When it agreed to buy GOJO, Clorox said the deal should produce at least $50 million of yearly cost savings once fully in place.

    What happened

    The filings read do not report savings achieved so far.

    Too early to tell
  4. Said on Aug 3, 2026

    On Aug 3, 2026, management said FY2027 adjusted EPS would be $5.70 to $6.00.

    What happened

    On Nov 2, 2026 it kept the range but said results would be closer to the low end.

    Too early to tell

08What could go wrong

What could go wrong for Clorox?

  • Concentration

    One customer buys a quarter of its products

    Walmart was 26% of FY2026 net sales, and the five largest customers about half. Losing shelf space or facing tougher terms at one of them would hit sales.

    Watch Walmart's share of net sales in the next 10-K.

  • Debt

    More debt after the GOJO deal

    Net debt rose from $2.3 billion to $4.9 billion in FY2026, and S&P cut its rating to BBB. The 10-K says further downgrades could follow if Clorox cannot reduce leverage.

    Watch Net debt and any rating action by S&P or Moody's.

  • Execution

    Integrating Purell

    Clorox paid about $2.1 billion for GOJO. When it announced the deal on Jan 22, 2026, it said it expected at least $50 million of yearly cost savings. The 10-K lists integrating recent acquisitions among its risks.

    Watch Health and Wellness organic growth and segment profit each quarter.

  • Raw-material prices

    Raw material and cost inflation

    Resin, chemicals, soybean oil and packaging drive costs. In Nov 2026 management said the cost environment had become more challenging and cut its FY2027 gross margin outlook to about 41.5%.

    Watch Gross margin each quarter against the company's outlook.

  • Demand

    Shoppers buying less

    Organic volume fell 7% in FY2026. Management said in Aug 2026 it expects a value-seeking consumer, and store brands compete on price.

    Watch Organic volume growth by segment.

  • Execution

    Leadership change

    The CEO asked the Board in May 2026 to find her successor for health reasons. On Oct 28, 2026 the Board appointed Fabian Garcia, at Unilever since 2020, as CEO from Jan 5, 2027. Several other senior roles changed in 2025 and 2026.

    Watch The CEO hand-over to Fabian Garcia on Jan 5, 2027.

  • Other

    Burt's Bees brand value

    The Burt's Bees trademark is carried at $322 million. In the FY2026 review, its estimated fair value was no more than 20% above that, and a lower estimate would mean an impairment charge (a write-down of its value).

    Watch Impairment charges in the 10-K or 10-Qs.

09Supporters vs. critics

What do supporters and critics point to?

Facts each side points to. We don't say which side is right.

What supporters point to

  • Clorox says over 80% of its sales come from brands holding the No. 1 or No. 2 market share position in their categories.
  • Purell joined on Apr 1, 2026, and Health and Wellness net sales rose 62% in Q1 FY2027, with organic growth of 23%.
  • Q1 FY2027 net sales rose 33% to $1.91 billion; Clorox says about 18 points of its 18% organic growth came from lapping the retailer stock drawdown of a year earlier.
  • International was the only segment with organic growth in FY2026, at 2%, and its net sales rose 11% in Q1 FY2027.
  • Clorox declared $4.96 of dividends per share in FY2026, up from $4.88, and raised its quarterly dividend 1% to $1.25 on Jul 31, 2026.

What critics point to

  • Walmart bought 26% of FY2026 net sales and the five largest customers about half; the same retailers sell store brands that compete with Clorox on price.
  • Net debt rose from $2.3 billion to $4.9 billion in FY2026, and S&P's long-term rating fell from BBB+ to BBB.
  • FY2026 net sales fell 5% and organic volume fell 7%; Household sales fell 11% and Lifestyle sales 14%.
  • FY2026 dividends paid of $602 million exceeded the $587 million of net income attributable to Clorox, and Clorox's own stockholders' equity fell to $90 million.
  • The chief executive is changing: Linda Rendle asked the Board in May 2026 to find a successor for health reasons, and Fabian Garcia, at Unilever since 2020, takes over on Jan 5, 2027.

10What to watch next

What should you watch next at Clorox?

Next event

Q2 FY2027 results

Feb 3, 2027

Expected, based on last year's date

  • Gross margin against the outlook

    Management said on Nov 2, 2026 that it now expects FY2027 gross margin of about 41.5%, against about 42% in its Aug 3, 2026 outlook. Q1 FY2027 gross margin was 40.4%, down 130 basis points (1.3 percentage points).

  • Purell savings and debt

    When it agreed to buy GOJO on Jan 22, 2026, Clorox said it expected at least $50 million of yearly cost savings once fully in place. Net debt was $4,974 million at Sep 30, 2026 (Cityfort calculation from the Q1 FY2027 10-Q).

  • A new chief executive

    Fabian Garcia, appointed by the Board on Oct 28, 2026, takes over as CEO from Linda Rendle on Jan 5, 2027, when Matthew Shattock becomes Independent Chair.

11Key facts

Key facts about Clorox

What does Clorox do?
The Clorox Company, based in Oakland, California, makes household products such as Clorox bleach and wipes, Glad bags, Fresh Step cat litter, Kingsford charcoal, Hidden Valley dressing, Brita filters and Burt's Bees. Clorox bought GOJO, the maker of Purell hand sanitizer, on Apr 1, 2026.
How does Clorox make money?
Clorox makes money by selling its brands to retailers, which resell them to shoppers. In FY2026 (the year to Jun 30, 2026), Health and Wellness, the cleaning and Purell segment, was the largest of Clorox's four segments, at $2,697 million or 40.1% of $6,720 million of net sales.
Which Clorox segment earns the most?
Clorox's Health and Wellness segment earned $678 million of segment adjusted EBIT in FY2026, about 57% of the $1,191 million the four segments earned combined (Cityfort calculation from the FY2026 10-K).
Who are Clorox's customers?
Walmart and its affiliates were Clorox's largest customer, at 26% of FY2026 net sales. Clorox's FY2026 10-K says its five largest customers were about half of net sales, which leaves about 24% for the other four and about 50% for all other customers (Cityfort calculation from the FY2026 10-K).
How big is Clorox?
Clorox had FY2026 net sales of $6,720 million, down 5% from $7,104 million in FY2025, and net income attributable to Clorox of $587 million, down from $810 million. Clorox had about 9,200 employees at Jun 30, 2026.
Who owns Clorox?
No single holder controls Clorox. In the filings listed in Clorox's 2026 proxy statementThe yearly filing about shareholder votes, the board and executive pay. Learn more, BlackRock held 8.23%, Vanguard Capital Management 7.35% and State Street 6.95% of the shares, and Clorox's directors and executive officers as a group held 0.51%.
How much debt does Clorox have?
Clorox's debt exceeded its cash by $4,925 million at Jun 30, 2026, up from $2,321 million a year earlier, after Clorox paid about $2.1 billion for GOJO and $476 million for P&G's 20% share of Glad (Cityfort calculation from the FY2026 10-K).
Does Clorox pay a dividend?
Clorox declared dividends of $4.96 per share in FY2026, up from $4.88 in FY2025. Clorox paid $602 million in dividends in FY2026, more than its $587 million of net income attributable to Clorox.

Terms on this page

Each explains the term in plain English, with the same number from other companies on Cityfort.

Go deeper

More detail from the same filings. Open any section.

12What it sells

12What it sells

What does Clorox sell?

Clorox makes everyday household products sold in supermarkets and big-box stores: bleach and wipes, trash bags, cat litter, charcoal, salad dressing, water filters and lip balm. Since April 2026 it also owns Purell hand sanitizer.
  • Health and Wellness

    Cleaning products such as Clorox bleach and wipes, Pine-Sol, Formula 409 and Liquid-Plumr, plus Purell and GOJO soap and sanitizer and CloroxPro products for hospitals, schools and offices. $2,697 million of net sales in FY2026.

  • Household

    Glad trash bags and food wraps, Fresh Step and Scoop Away cat litter, and Kingsford charcoal, sold in the US. $1,787 million of net sales in FY2026.

  • Lifestyle

    Hidden Valley ranch dressing and sauces, Brita water filters and Burt's Bees lip balm and skin care, sold in the US. $1,123 million of net sales in FY2026.

  • International

    Clorox, Poett, Pine-Sol, Clorinda, Chux, Glad and other brands sold outside the US. $1,113 million of net sales in FY2026.

What it does

  • Does: Makes and markets branded products that shoppers use up and buy again
  • Does: Sells mostly to retailers, which then sell to shoppers
  • Does: Sells to hospitals, schools and restaurants through distributors, mainly via Purell and CloroxPro

What it does not do

  • Does not: Does not run its own shops: mass retailers, grocers, warehouse clubs, dollar stores and online sellers stock its products
  • Does not: Does not earn most of its money abroad: 84% of FY2026 net sales were in the US
  • Does not: Does not report an operating income line in its income statement
13How the money flows

13How the money flows · FY2026

How does money flow through Clorox?

Money in

  • Net sales$6.7B
  • Other income, net$8M

The company

Clorox

$6.7B came in

Money out

  • Cost of products sold$3.9B
  • Selling, administration and research$1.2B
  • Advertising$749M
  • Interest$130M
  • Income taxes$190M
  • Share of outside partners$14M
  • Net income attributable to Clorox$587M
  1. Shoppers buy Clorox brands at Walmart and other stores; Clorox booked $6,720 million of net sales in FY2026.
  2. Making the products took $3,876 million: chemicals, plastic resin, cardboard, soybean oil and factory costs.
  3. Clorox spent $749 million on advertising and $1,182 million on selling, administration and research.
  4. Interest of $130 million and taxes of $190 million came next, and $14 million went to outside partners.
  5. The $587 million left was net income attributable to Clorox, less than the $602 million it paid out in dividends.
14What it needs to run

14What it needs to run

What does Clorox need to run?

  • Raw materials and packaging

    Plastic resin for bags, non-woven fabric for wipes, sodium hypochlorite for bleach, cardboard, soybean oil and other chemicals. The 10-K says some come from a single supplier.

  • Advertising

    Clorox spent $749 million on advertising in FY2026, $11.1 per $100 of net sales (Cityfort calculation from the FY2026 10-K).

  • People and research

    About 9,200 employees at Jun 30, 2026, 77% in the US. Its main research campus is in Pleasanton, California; research cost $116 million in FY2026.

  • Ordering and supply systems

    Clorox finished moving its US business to a new cloud-based ERP system, the software that runs orders, stock and invoicing, in Q3 FY2026. It says the digital program cost about $580 million.

15Where it sells

15Where it sells · FY2026

Where does Clorox sell?

  • United States83.8%
  • Outside the US16.2%
16Where growth could come from

16Where growth could come from

Where could Clorox's growth come from?

Management said in the Nov 2, 2026 earnings release that it still expects FY2027 net sales to grow 13% to 14%, about 9.5 points of it from GOJO. It still expects adjusted EPS of $5.70 to $6.00, with results closer to the low end of that range.
Management statement, Nov 2, 2026. Reported as a statement, not our forecast.
  • Purell (GOJO)

    New

    39 points of Health and Wellness growth, Q1 FY2027

    GOJO joined on Apr 1, 2026. Health and Wellness net sales rose 62% in Q1 FY2027; 39 points came from the acquisition and organic growth was 23%.

    Status: New, recently announced.

  • Sales after the systems switch

    Mixed

    Organic sales +18%, Q1 FY2027

    Retailers stocked up before the 2025 ERP switch, then ran stock down in FY2026. Clorox says about 18 points of the Q1 FY2027 organic growth came from lapping that drawdown (the quarter a year earlier included it).

    Status: Mixed, partly on track.

  • International

    Working

    Organic sales +2% in FY2026, +9% in Q1 FY2027

    The only segment that grew organically in FY2026. In Q1 FY2027 its net sales rose 11%, led by Latin America, the release says.

    Status: Working, on track against what the company said.

  • Professional customers

    Early

    8% of FY2026 net sales, up from 5%

    In October 2026 Clorox launched Clorox Purell ProCare, combining CloroxPro and GOJO under one sales and service team for professional and healthcare buyers.

    Status: Early, too early to judge.

Status compares progress with what the company itself said it would do: Working = on track against what the company said; Mixed = partly on track; Behind = behind the company's own plan; New = recently announced; Early = too early to judge.

17The company's own measures (non-GAAP)

17The company's own measures · FY2025 to Q1 FY2027

What do Clorox's own measures show?

Adjusted (non-GAAP) figures are Clorox's own measures, shown next to the nearest official (GAAP) figure. They are never added together; the rest of this page uses GAAP figures.
  • Official (GAAP): Diluted EPS, FY2026

    $4.81

    Company's own measure: Adjusted EPS, FY2026

    $5.53

    Clorox's own measure. It leaves out GOJO acquisition and integration costs and the cost of its digital capabilities and productivity investment.

  • Official (GAAP): Diluted EPS, FY2025

    $6.52

    Company's own measure: Adjusted EPS, FY2025

    $7.72

    Leaves out the $118 million loss on selling the Better Health vitamins business, $70 million of cyberattack insurance recoveries and digital investment costs.

  • Official (GAAP): Earnings before income taxes, FY2026

    $791M

    Company's own measure: Adjusted EBIT, FY2026

    $1.0B

    Adds back interest, $58 million of GOJO acquisition and integration costs and $59 million of digital investment costs.

  • Official (GAAP): Free cash flow, FY2026

    $405M

    Company's own measure: Adjusted free cash flow, FY2026

    $881M

    Clorox adds back the $476 million Glad payment to P&G to its free cash flowCash from operations minus spending on buildings and equipment. Learn more. Free cash flow here is operating cash flow less capital spending.

  • Official (GAAP): Net sales growth, FY2026

    −5.0%

    Company's own measure: Organic sales growth, FY2026

    −8%

    Leaves out the effect of acquisitions, divestitures and currency, so GOJO is excluded.

  • Official (GAAP): Diluted EPS, Q1 FY2027

    $1.39

    Company's own measure: Adjusted EPS, Q1 FY2027

    $1.55

    Leaves out GOJO acquisition and integration costs, among other items.

These are the company's own measures, defined by the company. They are not comparable across companies, and they are not added together. Each sits beside the nearest official (GAAP) figure.

Learn: Non-GAAP measures: what a company's "adjusted" numbers leave out

18Financial strength and debt

18Financial strength · Jun 30, 2026

How much debt does Clorox have?

At Jun 30, 2026 Clorox's debt exceeded its cash by $4.9 billion, about 4.2 times FY2026 EBITDA, which held only three months of GOJO.
  • Total debt$5.1B
  • Cash and investments$143M
  • Net debt (debt minus cash)$4.9B
  • Net worth (shareholders' money)$90M
Debt to equity
56.31×
$ of debt for every $1 of shareholders' money
Interest cover
7×
how many times operating profit covers interest
  • Debt is notes and loans payable ($1,086 million of commercial paper and credit-line borrowings), current maturities ($1 million) and long-term debt ($3,981 million). Net debt, net debt to EBITDA and interest cover (earnings before interest and taxes of $913 million ÷ interest expense of $130 million) are a Cityfort calculation from the FY2026 10-K.
  • Net debt rose from $2,321 million a year earlier, after Clorox paid about $2.1 billion for GOJO and $476 million for P&G's 20% share of Glad. In May 2026 it sold $1.5 billion of new notes.
  • Lease liabilities of $452 million are not counted as debt here.
  • Clorox's own stockholders' equity was only $90 million, down from $321 million, after $602 million of dividends and $256 million of buybacks in FY2026; that is why debt-to-equity reads 56.3.
  • Clorox states that current liabilities exceeded current assets by $949 million at Jun 30, 2026, mainly due to credit obligations due within a year. Its $1,964 million of revolving credit lines were undrawn.
  • At Sep 30, 2026, debt was $5,158 million and cash $184 million, so net debt was $4,974 million (Cityfort calculation from the Q1 FY2027 10-Q).
19Who owns it

19Who owns it · ownership as of Aug 31, 2026

Who owns Clorox?

No single holder controls Clorox. Directors and executive officers as a group (16 people) held 613,362 shares, or 0.51% (Cityfort calculation from the 2026 proxy statement).
Officers and directors (as a group), shares
0.5%
Share classes
Clorox share classes: shares outstanding (millions) and votes per share
ClassShares (millions)Votes per shareHeld by% of shares% of votesTraded
Common stock (120,938,184 shares at the Sep 21, 2026 record date (2026 proxy statement). Clorox has one class of shares.)120.91Public shareholders––Yes
Holders of 5% or more
Clorox holders of 5% or more, from the proxy statement or later Schedule 13G filings; each row shows its own date
HolderSharesVotesAs ofSourceNote
BlackRock8.2%–Jun 30, 2025S159,954,343 shares, from a Schedule 13G/A filed Jul 17, 2025, as of Jun 30, 2025, as listed in the 2026 proxy.
Vanguard Capital Management7.4%–Mar 31, 2026S158,889,552 shares, from a Schedule 13G filed Apr 29, 2026, as of Mar 31, 2026, as listed in the 2026 proxy.
State Street7.0%–Dec 31, 2023S158,410,519 shares, from a Schedule 13G/A filed Jan 25, 2024, as of Dec 31, 2023, as listed in the 2026 proxy.

From the company's proxy statement (DEF 14A), later Schedule 13G filings and the share counts on its latest annual or quarterly report. Each holder row shows the date of its own filing.

Learn: How to read a proxy statement (DEF 14A): Nvidia's 2026 proxy · Form 4 insider filings: who files, the codes and the footnotes

20What it does with profit

20What it does with profit

What does Clorox do with its profit?

Dividends are per share declared in each fiscal year; FY2022 reads lower ($3.48) because of declaration timing, though $4.64 was paid. FY2026 dividends paid of $602 million were more than the $587 million of net income attributable to Clorox. The quarterly dividend rose 1% to $1.25 on Jul 31, 2026. Of the $2.0 billion buyback approved in May 2018, $876 million remained at Sep 30, 2026, with no shares bought in Q4 FY2026 or Q1 FY2027.

Dividend per share

$4.96FY2026

Dividend paid for each share, by financial year.

$ per share

See the numbers
Dividend per share ($ per share)
YearDividend per shareShare of profit paid out
FY2022$3.48–
FY2023$4.72–
FY2024$4.80–
FY2025$4.88–
FY2026$4.96–
  • Buyback · Jun 30, 2022

    FY2022: bought back its own shares for $25 million.

    $25M

  • Buyback · Jun 30, 2025

    FY2025: bought back its own shares for $332 million.

    $332M

  • Buyback · Jun 30, 2026

    FY2026: bought back its own shares for $256 million.

    $256M

  • Money raised · May 11, 2026

    Sold $1.5 billion of senior notes due 2031, 2033 and 2036; the $1.25 billion term loan drawn for GOJO in April 2026 was settled in May.

    $1.5B

21Governance signals

21Governance signals

What do Clorox's governance filings show?

Auditor
Ernst & Young LLP, since 2003
Auditor changes
None in the period covered
Audit qualifications
None reported
Related-party dealings
The 2026 proxy says Clorox reviews all transactions with directors, officers and their families and does not believe any had a material interest in them. The 10-K reports equity investments of $48 million in partly owned businesses, mainly contract manufacturers and raw material suppliers.
Credit rating
S&P Global Ratings and Moody's (as stated in Clorox's FY2026 10-K) BBB long-term, A-2 short-term (S&P) / Baa1 long-term, P-2 short-term (Moody's) (outlook Not stated in the 10-K), Jun 30, 2026

A credit rating describes the company's ability to repay debt. It is not a rating of the share.

Flags to know about

  • other

    S&P lowered its rating in FY2026

    S&P's long-term rating was BBB at Jun 30, 2026, against BBB+ a year earlier; Moody's held Baa1. Clorox's 10-K warns that further downgrades could follow if it cannot reduce leverage, improve results or integrate recent acquisitions.

  • other

    New chief executive from Jan 5, 2027

    An 8-K filed Oct 29, 2026 says the Board appointed Fabian Garcia as CEO and a director, effective Jan 5, 2027. Linda Rendle steps down as CEO and Chair on that date and stays as a senior advisor through Apr 2, 2027; Lead Independent Director Matthew Shattock becomes Independent Chair.

  • disclosure

    What Clorox does not report

    The FY2026 10-K names no competitor and no customer other than Walmart, and Clorox files no earnings-call transcripts with the SEC. The date and outlook of the S&P rating change are not in the filings read.

  • other

    Policy bars hedging Clorox stock

    The 2026 proxy says Clorox policy bars directors and executive officers from hedging Clorox stock or using it as loan collateral.

22How it got here

22How it got here

How did Clorox get here?

  1. 1913

    Milestone

    Founded in Oakland

    Clorox was founded in Oakland, California, where it is still based.

  2. 2023

    Crisis

    Cyberattack disrupts operations

    An attack found on Aug 14, 2023 caused wide-scale disruption and cut sales and earnings in FY2024 before operations returned to normal.

  3. 2024

    Milestone

    Leaves Argentina

    Clorox sold its Argentina business in FY2024, booking a $240 million loss.

  4. 2025

    Milestone

    Sells vitamins business

    The Better Health vitamins business was sold in FY2025 for $128 million, with a $118 million loss.

  5. 2025

    Business-model change

    New US ordering system

    Retailers stocked up before the 2025 ERP switch, adding about 3.5 points to FY2025 sales; running that stock down cut FY2026 sales by about 7.5 points.

  6. 2026

    Business-model change

    Takes full control of Glad

    The Glad venture with P&G ended on Jan 31, 2026, and Clorox bought P&G's 20% share for $476 million.

  7. 2026

    Business-model change

    Buys GOJO, maker of Purell

    Announced Jan 22, 2026 and completed Apr 1, 2026 for about $2.1 billion in cash, funded with commercial paper and new debt.

  8. 2026

    Milestone

    CEO search begins

    On May 28, 2026 Clorox announced that CEO Linda Rendle had asked the Board to find a successor.

  9. 2026

    Milestone

    New CEO named

    On Oct 28, 2026 the Board appointed Fabian Garcia as CEO, effective Jan 5, 2027, when Linda Rendle steps down and Matthew Shattock becomes Independent Chair.

23Sources and changes

Where every number on this page comes from

Sources (33 documents)
  1. S1Form 10-K FY2026 (fiscal year ended June 30) · SEC EDGAR · Tier 1: company or exchange filing · Aug 7, 2026
  2. S2Form 10-K FY2026 Exhibit 99.1 (MD&A and financial statements) · SEC EDGAR · Tier 1: company or exchange filing · Aug 7, 2026
  3. S4Form 10-K FY2025 Exhibit 99.1 (MD&A and financial statements) · SEC EDGAR · Tier 1: company or exchange filing · Aug 8, 2025
  4. S6Form 10-K FY2024 Exhibit 99.1 (MD&A and financial statements) · SEC EDGAR · Tier 1: company or exchange filing · Aug 8, 2024
  5. S8Form 10-K FY2023 Exhibit 99.1 (MD&A and financial statements) · SEC EDGAR · Tier 1: company or exchange filing · Aug 10, 2023
  6. S10Form 10-K FY2022 Exhibit 99.1 (MD&A and financial statements) · SEC EDGAR · Tier 1: company or exchange filing · Aug 10, 2022
  7. S11Form 10-Q Q1 FY2027 (quarter ended Sep 30, 2026) · SEC EDGAR · Tier 1: company or exchange filing · Nov 2, 2026
  8. S12Form 10-Q Q3 FY2026 (Mar 31, 2026) · SEC EDGAR · Tier 1: company or exchange filing · Apr 30, 2026
  9. S13Form 10-Q Q2 FY2026 (Dec 31, 2025) · SEC EDGAR · Tier 1: company or exchange filing · Feb 3, 2026
  10. S14Form 10-Q Q1 FY2026 (Sep 30, 2025) · SEC EDGAR · Tier 1: company or exchange filing · Nov 3, 2025
  11. S15DEF 14A proxy statement 2026 · SEC EDGAR · Tier 1: company or exchange filing · Oct 7, 2026
  12. S168-K Ex. 99.1 earnings press release Q1 FY2027 · SEC EDGAR · Tier 1: company or exchange filing · Nov 2, 2026
  13. S178-K Ex. 99.2 supplemental information Q1 FY2027 · SEC EDGAR · Tier 1: company or exchange filing · Nov 2, 2026
  14. S188-K Ex. 99.1 earnings press release Q4 FY2026 · SEC EDGAR · Tier 1: company or exchange filing · Aug 3, 2026
  15. S198-K Ex. 99.2 supplemental information Q4 FY2026 · SEC EDGAR · Tier 1: company or exchange filing · Aug 3, 2026
  16. S208-K Ex. 99.1 earnings press release Q3 FY2026 · SEC EDGAR · Tier 1: company or exchange filing · Apr 30, 2026
  17. S218-K Ex. 99.2 supplemental information Q3 FY2026 · SEC EDGAR · Tier 1: company or exchange filing · Apr 30, 2026
  18. S228-K Ex. 99.1 earnings press release Q2 FY2026 · SEC EDGAR · Tier 1: company or exchange filing · Feb 3, 2026
  19. S238-K Ex. 99.2 supplemental information Q2 FY2026 · SEC EDGAR · Tier 1: company or exchange filing · Feb 3, 2026
  20. S248-K Ex. 99.1 earnings press release Q1 FY2026 · SEC EDGAR · Tier 1: company or exchange filing · Nov 3, 2025
  21. S258-K Ex. 99.2 supplemental information Q1 FY2026 · SEC EDGAR · Tier 1: company or exchange filing · Nov 3, 2025
  22. S268-K Ex. 99.1 earnings press release Q4 FY2025 · SEC EDGAR · Tier 1: company or exchange filing · Jul 31, 2025
  23. S278-K Ex. 99.1 earnings press release Q3 FY2025 · SEC EDGAR · Tier 1: company or exchange filing · May 5, 2025
  24. S288-K Ex. 99.1 earnings press release Q2 FY2025 · SEC EDGAR · Tier 1: company or exchange filing · Feb 3, 2025
  25. S298-K Ex. 99.1 GOJO acquisition announced (Jan 22, 2026) · SEC EDGAR · Tier 1: company or exchange filing · Jan 22, 2026
  26. S308-K Ex. 99.1 GOJO acquisition completed (Apr 1, 2026) · SEC EDGAR · Tier 1: company or exchange filing · Apr 1, 2026
  27. S328-K debt offering (Item 8.01), May 11, 2026 · SEC EDGAR · Tier 1: company or exchange filing · May 11, 2026
  28. S33Form 10-Q for Q3 FY2025 · SEC EDGAR · Tier 1: company or exchange filing · May 5, 2025
  29. S34Form 10-Q for Q2 FY2025 · SEC EDGAR · Tier 1: company or exchange filing · Feb 3, 2025
  30. S35Form 10-Q for Q1 FY2025 · SEC EDGAR · Tier 1: company or exchange filing · Oct 30, 2024
  31. S36Form 10-Q for Q3 FY2024 · SEC EDGAR · Tier 1: company or exchange filing · Apr 30, 2024
  32. S37Form 10-Q for Q2 FY2024 · SEC EDGAR · Tier 1: company or exchange filing · Feb 1, 2024
  33. S388-K CEO succession (Item 5.02), filed Oct 29, 2026 · SEC EDGAR · Tier 1: company or exchange filing · Oct 29, 2026
Changes to this page (v1 · Nov 20, 2026)
  1. v1 · Nov 20, 2026First version. (first version)

Numbers come only from tier 1 and tier 2 sources. Read how we research.

Disclaimer

For learning only. Cityfort is not a registered investment adviser or broker-dealer and does not recommend buying or selling any security. Prices shown are dated and may be out of date.

Investing in securities involves risk, including loss of capital. Before making any investment decision, do your own research and consider consulting a registered investment adviser or other qualified professional.

Cityfort, its owners and contributors may or may not hold securities of companies covered. Cityfort is not paid by any company it covers. Content is not an offer or solicitation to buy or sell any security, including in any initial public offering.

Read the positions policy
Read the full disclaimer

Cityfort publishes general educational content that explains how listed companies work. Cityfort is not registered with the US Securities and Exchange Commission or any state securities regulator as an investment adviser, and is not a broker-dealer or a member of FINRA. Cityfort does not provide investment, tax or legal advice, recommendations, ratings, price targets or any opinion on whether to buy, sell or hold any security. Nothing on the site is tailored to any person's circumstances.

All information is taken from publicly available sources, mainly company filings with the SEC, which are listed on each page with dates. We work to keep it accurate and correct errors publicly, but we do not guarantee that it is complete, accurate or up to date. Any market price or price-based ratio shown is dated, may be out of date by the time you read it, and is included only to explain concepts.

Statements by company management, including forward-looking statements and guidance, are reported as the company's statements, with their date and source; they are not our forecasts. Adjusted (non-GAAP) figures are the company's own measures and are shown next to the official (GAAP) figures.